The new, state-of-the-art manufacturing facility, operated by Heritage Pharma Labs Inc. (“Heritage Pharma Labs”), consists of dispensaries/pharmacies and multiple manufacturing suites to hold fixed and portable equipment to perform pharmaceutical operations like mixing, granulation, drying, milling/sieving, compaction, extrusion/spheronization, blending, compression, coating, encapsulation and packaging
AbbVie’s Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis. Atopic dermatitis, a chronic inflammatory skin disease, is characterized by skin erosion, oozing and crusting, redness, intense itching (pruritus) and dry skin.12 Symptoms can appear as a rash on the skin, or the skin may become thickened and leathery.
GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.
